Publications

 

PUBLICATIONS

-

December 2017 – IDF Congress 2017

A phase I study to investigate the safety, tolerability and pharmacokinetics of a biased GLP-1R antibody Glutazumab

Abstract number: AD-1719

Poster number: P-0352